Meet Our Executive Team

oncology-analytics-rick-deanRick Dean
Chief Executive Officer
Rick Dean serves as CEO of Oncology Analytics. Mr. Dean brings more than two decades of experience to Oncology Analytics, including successfully leading and growing innovative healthcare companies through various stages of maturation. Mr. Dean joined Oncology Analytics from Optum, the healthcare services arm of UnitedHealth Group. At Optum, Mr. Dean was a founding member of Optum Ventures, a venture capital fund focused on digital health innovation. Prior to Optum Ventures, he led global sales and growth for Optum Analytics.
Mr. Dean joined Optum after the acquisition of Humedica, a transformative population health and analytics company, where he was the company’s Chief Growth Officer. Prior to Humedica, Mr. Dean was senior vice president of North American sales for Sentillion, a highly successful venture backed healthcare company that was acquired by Microsoft in 2010. Mr. Dean is a past Board member of AMGA Analytics, the informatics subsidiary of the American Medical Group Association.

Mr. Dean earned a Bachelor of Science degree in Finance from the University of North Carolina.

oncology-analytics-marc-fishmanMarc Fishman, MD
Executive Chairman
Dr. Fishman founded Oncology Analytics (OA) in 2008. OA has grown rapidly, currently providing comprehensive oncology benefits management for members of health plans diagnosed with cancer. Through clinical research, patented technology and patient-focused customer services, OA ensures treating oncologists have the information they need to deliver the most efficacious, least toxic and most affordable chemotherapy treatments available to their patients.
Inc. Magazine’s 2013 Inc. 500|5000 list named OA in the top 20 of the fastest growing private health care companies in the United States. Dr. Fishman is board-certified in Internal Medicine and Hematology. Dr. Fishman developed his perspective on health care management and funding mechanisms through a wide variety of clinical experiences, including work in Kenya, New Zealand, Canada and Australia, in addition to the United States. Seeing the differences in care delivery systems, policy priorities and financing methods has provided him with unique insights into opportunities for improvement in the United States, which he is bringing to the market through OA. His combination of more than 20 years of clinical treatment experience and exposure to multi-national health systems have reinforced his commitment to value-based care for providing quality cancer treatment to all those who need it in the face of the enormous costs, waste and poorly aligned incentives in medical care.
oncology-analytics-richard-wilderRichard Wilder, MD, MBA
Chief Medical Officer
Dr. Wilder obtained an MD degree from the University of Maryland and an MBA degree from Johns Hopkins University. He completed an internal medicine internship at the Greater Baltimore Medical Center, a radiation oncology residency at the University of Arizona, and an ASTRO research fellowship at the Stanford University Medical Center. Dr. Wilder is board-certified in Radiation Oncology. He has worked on the faculty of leading academic centers such as the University of California, San Francisco and the MD Anderson Cancer Center.
Recently, Dr. Wilder served for 2 1/2 years as interim chair of the Department of Radiation Oncology at the Moffitt Cancer Center. During this time, he worked on radiation oncology treatment guidelines. Also, he served for five years as a Kidney and Testicular Cancer Panel Member for the NCCN, helping to write national evidence-based treatment guidelines. In addition, since 2002 he has served nationally as an oral board examiner for the American Board of Radiology. Dr. Wilder joined Oncology Analytics in 2016 as its Chief Medical Officer.
oncology-analytics-debbie-rosamelia Debbie Rosamelia
Chief Information Officer
Debbie Rosamelia joined Oncology Analytics in February of 2015, and she is responsible for building an infrastructure that will take the company into the future and allow for seamless growth. Debbie comes to OA with 30 years of experience in her field. Her background working with other companies has helped OA grow by applying technology where it makes sense and by improving proprietary software processes.
Over the years Debbie has been on the Board of Directors of many professional organizations. She has served in leadership positions for multiple computer users groups, both on a local and national level. Debbie holds a bachelor’s degree from Barry University in Miami Lakes, and is a member of Alpha Chi and Phi Theta Kappa Associations.
oncology-analytics-ashley-brevdaAshley Brevda, Esq.
In-house Counsel and Chief Compliance Officer
Ashley Brevda is In-house Counsel and Chief Compliance Officer for Oncology Analytics. Her practice includes providing leadership for the company’s legal and regulatory affairs and corporate governance activities, advising on compliance matters under state and federal laws, including HIPAA, directing legal strategy and overseeing outside counsel. Prior to joining OA, Ashley worked in marital and family law with a focus on complex high net worth divorce cases and family issues, such as visitation, timesharing and parenting.
She earned her Juris Doctor degree cum laude from the University of Florida Levin College of Law. Ashley is currently a member of the Health Law Section of the Florida Bar, the American Health Lawyers Association, Association for Corporate Counsel and the Palm Beach County Bar Association. She serves as a Trustee and Young Leader Society Co-Chair of the Jewish Woman’s Foundation of Greater Palm Beaches and was recognized by the Palm Beach County Bar Association for her pro bono service. Ashley graduated from the Honors Program at the University of Florida cum laude and Phi Beta Kappa with a bachelor’s degree in History and a minor in Business Administration.
oncology-analytics-tammy-wattTamara Watt, MBA
Senior Vice President, Sales and Marketing
As Oncology Analytics SVP of Sales and Marketing, Tammy Watt is committed to assisting health plans achieve their clinical and financial goals by identifying solutions that provide sustainable win-win partnerships between the health plan, their providers and their patients.
She has nearly 30 years experience in executive sales and business development roles with leading health care payers, medical providers and disease management companies, including Anthem Blue Cross, Matria Healthcare (now Alere), Health Net, Insight Health Corporation and Centinela Hospital. Tammy has a MBA from the Anderson School of Management at UCLA and a BS in Biology from Stanford University.
oncology-analytics-danielle-fishermanDanielle Fishman
Senior Director of Operations
Danielle Fishman, co-founder of Oncology Analytics, has contributed to the company’s growth through her strong leadership in operations and business acumen. In the early years, Danielle was responsible for OA’s business development, including compliance, accreditation, accounting, human resources, marketing and provider relations.
Danielle is currently responsible for leading the CRS team and quality initiatives in the United States, as well as our sister company Soluciones Analiticas de Salud in Puerto Rico. Danielle holds a BSc in Hospitality Administration from Boston University. In her spare time, Danielle is an avid equestrian and loves to travel.